Qiu Tan

Title: Qiu Tan: Innovator in Pharmaceutical Chemistry

Introduction

Qiu Tan is a notable inventor based in Jiangyin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific mutations in the epidermal growth factor receptor (EGFR). His work is crucial for advancing treatments for various medical conditions, including cancer.

Latest Patents

Qiu Tan holds a patent for "2-arylamino pyridine, pyrimidine or triazine derivatives, preparation method and use thereof." This patent describes a novel class of compounds that can act on mutated forms of EGFR, such as the L858R activating mutant and the T790M resistance mutant. These derivatives are designed for the treatment and prevention of cancer, showcasing their potential in pharmaceutical applications.

Career Highlights

Qiu Tan is currently employed at Wuxi Shuangliang Biotechnology Co., Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to innovative solutions in the pharmaceutical industry. His expertise in synthesizing and utilizing 2-arylamino pyridine, pyrimidine, or triazine derivatives has positioned him as a key figure in his field.

Collaborations

Qiu Tan collaborates with talented professionals such as Jiaquan Wu and Haijun Zhang. These partnerships enhance the research and development efforts at Wuxi Shuangliang Biotechnology Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Qiu Tan's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has the potential to improve treatment options for patients suffering from cancer and other medical conditions.